Literature DB >> 23867217

Effects of interleukin-6 on the expression of tight junction proteins in isolated cerebral microvessels from yearling and adult sheep.

Susan S Cohen1, May Min, Erin E Cummings, Xiaodi Chen, Grazyna B Sadowska, Surendra Sharma, Barbara S Stonestreet.   

Abstract

OBJECTIVES: The blood-brain barrier is a selective diffusion barrier between brain parenchyma and the intravascular compartment. Tight junctions are integral components of the blood-brain barrier. Pro-inflammatory cytokines are important in the pathogenesis of brain injury and could modify the protein constituents of tight junctions. We hypothesized that interleukin-6 (IL-6) downregulates key protein constituents of endothelial tight junctions (e.g. occludin and claudin-5).
METHODS: We examined the effects of IL-6 on tight junction protein expression using an in vitro blood-brain barrier model. We isolated microvessels from yearling and adult ovine cerebral cortex and placed them into culture with IL-6 concentrations of 0 (control, phosphate-buffered saline), 1, 10, and 100 ng/ml for 24 h. Cerebral microvessels were harvested, Western immunoblot performed for occludin and claudin-5, densitometry performed, and results expressed as a ratio to control values.
RESULTS: Western immunoblot analysis showed that treatment with 100 ng/ml of IL-6, but not the lower concentrations, reduced (p < 0.05) occludin expression in microvessels from yearling and adult sheep and claudin-5 in microvessels from adult sheep. However, treatment with 10 ng/ml of IL-6 increased claudin-5 in microvessels from yearling sheep. The percent of lactate dehydrogenase released from the microvessels into the surrounding media was not increased by IL-6 treatment, suggesting that the reductions in tight junction proteins did not result from cell death. Treatment of adult cerebral cortical microvessels with IL-6 preincubated with anti-IL-6 monoclonal antibodies partially attenuated the reduction in claudin-5.
CONCLUSION: We conclude that IL-6 modulates tight junction protein expression in cerebral cortical microvessels from yearling and adult sheep.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23867217      PMCID: PMC3827681          DOI: 10.1159/000350470

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  41 in total

Review 1.  Claudin-based barrier in simple and stratified cellular sheets.

Authors:  Shoichiro Tsukita; Mikio Furuse
Journal:  Curr Opin Cell Biol       Date:  2002-10       Impact factor: 8.382

2.  Interleukin-6 mediates pulmonary vascular permeability in a two-hit model of ventilator-associated lung injury.

Authors:  Ozlem U Gurkan; Chaoxia He; Rachel Zielinski; Hamid Rabb; Landon S King; Jeffrey M Dodd-o; Franco R D'Alessio; Neil Aggarwal; David Pearse; Patrice M Becker
Journal:  Exp Lung Res       Date:  2011-11-01       Impact factor: 2.459

3.  Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier.

Authors:  Carola Förster; Malgorzata Burek; Ignacio A Romero; Babette Weksler; Pierre-Olivier Couraud; Detlev Drenckhahn
Journal:  J Physiol       Date:  2008-02-07       Impact factor: 5.182

4.  Energy state of bovine cerebral microvessels: comparison of isolation methods.

Authors:  I Sussman; M P Carson; A L McCall; V Schultz; N B Ruderman; K Tornheim
Journal:  Microvasc Res       Date:  1988-03       Impact factor: 3.514

5.  IL-6 increases endothelial permeability in vitro.

Authors:  N Maruo; I Morita; M Shirao; S Murota
Journal:  Endocrinology       Date:  1992-08       Impact factor: 4.736

6.  Vascular endothelial growth factor and interleukin-6 are correlated with serous retinal detachment in central retinal vein occlusion.

Authors:  Hidetaka Noma; Hideharu Funatsu; Tatsuya Mimura
Journal:  Curr Eye Res       Date:  2011-10-06       Impact factor: 2.424

7.  Tumour necrosis factor-alpha affects blood-brain barrier permeability and tight junction-associated occludin in acute liver failure.

Authors:  Sa Lv; Hong-Li Song; Ying Zhou; Li-Xin Li; Wei Cui; Wen Wang; Pei Liu
Journal:  Liver Int       Date:  2010-05-18       Impact factor: 5.828

8.  Clinical chorioamnionitis, elevated cytokines, and brain injury in term infants.

Authors:  Lina F Shalak; Abbot R Laptook; Hasan S Jafri; Octavio Ramilo; Jeffrey M Perlman
Journal:  Pediatrics       Date:  2002-10       Impact factor: 7.124

9.  The development of the somatosensory evoked potential in the unanaesthetized fetal sheep.

Authors:  C J Cook; P D Gluckman; B M Johnston; C Williams
Journal:  J Dev Physiol       Date:  1987-10

10.  Junctional complexes in various epithelia.

Authors:  M G FARQUHAR; G E PALADE
Journal:  J Cell Biol       Date:  1963-05       Impact factor: 10.539

View more
  21 in total

1.  Inter-alpha inhibitor proteins attenuate lipopolysaccharide-induced blood-brain barrier disruption and downregulate circulating interleukin 6 in mice.

Authors:  Aric F Logsdon; Michelle A Erickson; Xiaodi Chen; Joseph Qiu; Yow-Pin Lim; Barbara S Stonestreet; William A Banks
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-24       Impact factor: 6.200

2.  Anti-IL-6 neutralizing antibody modulates blood-brain barrier function in the ovine fetus.

Authors:  Jiyong Zhang; Grazyna B Sadowska; Xiaodi Chen; Seon Yeong Park; Jeong-Eun Kim; Courtney A Bodge; Erin Cummings; Yow-Pin Lim; Oleksandr Makeyev; Walter G Besio; John Gaitanis; William A Banks; Barbara S Stonestreet
Journal:  FASEB J       Date:  2015-01-21       Impact factor: 5.191

Review 3.  The mucosal immune system: master regulator of bidirectional gut-brain communications.

Authors:  Nick Powell; Marjorie M Walker; Nicholas J Talley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-18       Impact factor: 46.802

4.  Transitory loss of glia and the subsequent modulation in inflammatory cytokines/chemokines regulate paracellular claudin-5 expression in endothelial cells.

Authors:  Ryan B Camire; Holly J Beaulac; Colin L Willis
Journal:  J Neuroimmunol       Date:  2015-05-13       Impact factor: 3.478

5.  Astrocytic responses to high glucose impair barrier formation in cerebral microvessel endothelial cells.

Authors:  Jodi Garvin; Marharyta Semenikhina; Qiuli Liu; Kevin Rarick; Elena Isaeva; Vladislav Levchenko; Alexander Staruschenko; Oleg Palygin; David Harder; Susan Cohen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2022-04-12       Impact factor: 3.210

6.  Klebsiella pneumoniae induces an inflammatory response in an in vitro model of blood-retinal barrier.

Authors:  C Motta; M Salmeri; C D Anfuso; A Amodeo; M Scalia; M A Toscano; G Giurdanella; M Alberghina; G Lupo
Journal:  Infect Immun       Date:  2013-12-09       Impact factor: 3.441

7.  Association of a functional Claudin-5 variant with schizophrenia in female patients with the 22q11.2 deletion syndrome.

Authors:  Yiran Guo; Larry N Singh; Yuankun Zhu; Raquel E Gur; Adam Resnick; Stewart A Anderson; Jorge I Alvarez
Journal:  Schizophr Res       Date:  2019-10-23       Impact factor: 4.939

8.  Effects of neuromyelitis optica-IgG at the blood-brain barrier in vitro.

Authors:  Yukio Takeshita; Birgit Obermeier; Anne C Cotleur; Simona F Spampinato; Fumitaka Shimizu; Erin Yamamoto; Yasuteru Sano; Thomas J Kryzer; Vanda A Lennon; Takashi Kanda; Richard M Ransohoff
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-12-19

9.  Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions.

Authors:  Keith D Rochfort; Laura E Collins; Ronan P Murphy; Philip M Cummins
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

10.  miR-142-3p Expression Is Predictive for Severe Traumatic Brain Injury (TBI) in Trauma Patients.

Authors:  Cora Rebecca Schindler; Mathias Woschek; Jan Tilmann Vollrath; Kerstin Kontradowitz; Thomas Lustenberger; Philipp Störmann; Ingo Marzi; Dirk Henrich
Journal:  Int J Mol Sci       Date:  2020-07-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.